This is an application for an extension of a MERIT award to study natural killer T cells (NKT cells). Evidence of progress during the previous funding period is supported by 30 publications. Some of the main published findings were;1) Determination that NKT cells can be activated independently of antigen presentation, particularly in the presence of IL-12. This mechanism allows NKT cells to become activated during viral Infections. 2) The identification of antigens from pathogenic Borrelia burgdorferi spirochetes that can activate NKT cells. These glycolipid antigens have diacylglycerol as the lipid moiety, a lipid that is found in many pathogenic microbes. We showed that NKT cells are important for preventing arthritis in a mouse model of Lyme disease. 3) We have described a mechanism for the THI skewiing of NKT cell cytokine responses that is not dependent on TCR affinity, but which is dependent on increased antigenic stability in vivo. This finding may aid in the development of new ligands for NKT cell activation. In the extension period, we will invesitgate the transcriptional control of Thi and Th2 cytokine synthesis by NKT cells. We also will analyze how NKT cells contribute to host defense in the lung following infection with S. pneumoniae. Additionally, we will explore how components of the autophagy machinery influence NKT cell differentiation and CD1d antigen presentation.

Public Health Relevance

NKT cells are a unique lymphocyte population that combine features ofthe innate and adaptive immunity. They have been reported to influence many types of immune responses, and activation of NKT cells is being explored as a potential cancer immune therapy. Our experimental results will help our understanding as to how these cells function in immune protection, which may lead to new immune therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI071922-20
Application #
8237054
Study Section
Special Emphasis Panel (NSS)
Program Officer
Miller, Lara R
Project Start
1991-04-01
Project End
2016-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
20
Fiscal Year
2012
Total Cost
$852,188
Indirect Cost
$320,981
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Chandra, Shilpi; Wingender, Gerhard; Greenbaum, Jason A et al. (2018) Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment. J Immunol 200:1995-2003
Chandra, Shilpi; Gray, James; Kiosses, William B et al. (2018) Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae. Nat Commun 9:4279
Hartmann, Nadine; Harriff, Melanie J; McMurtrey, Curtis P et al. (2018) Role of MAIT cells in pulmonary bacterial infection. Mol Immunol 101:155-159
Zhao, Meng; Svensson, Mattias N D; Venken, Koen et al. (2018) Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. Nat Commun 9:2627
Sag, Duygu; Özkan, Müge; Kronenberg, Mitchell et al. (2017) Improved Detection of Cytokines Produced by Invariant NKT Cells. Sci Rep 7:16607
Crosby, Catherine M; Kronenberg, Mitchell (2016) Invariant natural killer T cells: front line fighters in the war against pathogenic microbes. Immunogenetics 68:639-48
Engel, Isaac; Seumois, Grégory; Chavez, Lukas et al. (2016) Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat Immunol 17:728-39
Birkholz, Alysia; Nem?ovi?, Marek; Yu, Esther Dawen et al. (2015) Lipid and Carbohydrate Modifications of ?-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation. J Biol Chem 290:17206-17
Chandra, Shilpi; Zhao, Meng; Budelsky, Alison et al. (2015) A new mouse strain for the analysis of invariant NKT cell function. Nat Immunol 16:799-800
Birkholz, Alysia M; Howell, Amy R; Kronenberg, Mitchell (2015) The Alpha and Omega of Galactosylceramides in T Cell Immune Function. J Biol Chem 290:15365-70

Showing the most recent 10 out of 60 publications